Doxazosin (Mesylate) (Doxazosin (Mesylate))
Overview of Doxazosin (Mesylate)
Doxazosin (Mesylate) is a quinazoline derivative that blocks certain of the alpha adrenergic receptors, used as an anihypertensive agent. Doxazosin (Mesylate) is adrenergic alpha1 blocking agent. Doxazosin (Mesylate) is used to treat hypertension (high blood pressure). It lowers the blood pressure by relaxing and dilating the blood vessels. It may also be used for treating heart failure and in males for prostate enlargement symptoms such as urinary hesitancy and/or urgency.
Indication of Doxazosin (Mesylate)
Doxazosin Mesylate is primarily indicated in conditions like Benign prostatic hyperplasia, Hypertension.
Contraindication of Doxazosin (Mesylate)
No data regarding the contra indications of Doxazosin (Mesylate) is available.
Side Effects of Doxazosin (Mesylate)
The severe or irreversible adverse effects of Doxazosin (Mesylate), which give rise to further complications include Orthostatic hypotension.,The signs and symptoms that are produced after the acute overdosage of Doxazosin (Mesylate) include Hypotension.,The symptomatic adverse reactions produced by Doxazosin (Mesylate) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Nausea, Vomiting, Diarrhea, Anxiety, Dyspnea, Palpitation, Insomnia, Lethargy, VertigoX, Somnolence, Edema, Sexual dysfunction, Syncope, Rhinitis, Chest pain, dizziness.
Precautions of Doxazosin (Mesylate)
Doxazosin should be used with caution in patients with hepatic disease (the drug is primarily metabolized by the liver) and administration of noral doses of drug may results in exaggerated effects in these patients. Patients with renal impairment should be monitored carefully for exaggerated effects, such as first-dose hypotensive reaction or prolonged hypotension. It is classified as FDA pregnancy category B. This medication should be used only when clearly needed during pregnancy or lactation. Blood pressure should be monitored for 2-6 hours following the first dose and with each subsequent increase in dose because postural hypotensive effects are most likely to occur during this time. Dosages should be adjusted as necessary depending on patient tolerance as evidenced by standing blood pressure. It should not be administered to any patient who has hypotension. Elderly patients are more likely to be susceptible to hypotensive effects.